| Literature DB >> 26635930 |
Poay Huan Loh1, Christos V Bourantas1, Pak Hei Chan1, Nikolaj Ihlemann1, Fin Gustafsson1, Andrew L Clark1, Susanna Price1, Carlo Di Mario1, Neil Moat1, Farqad Alamgir1, Rodrigo Estevez-Loureiro1, Lars Søndergaard1, Olaf Franzen1.
Abstract
Many patients with left ventricular systolic dysfunction have concomitant mitral regurgitation (MR). Their symptoms and prognosis worsen with increasing severity of MR. Percutaneous MitraClip(®) can be used safely to reduce the severity of MR even in patients with advanced heart failure and is associated with improved symptoms, quality of life and exercise tolerance. However, a few patients with very poor left ventricular systolic function may experience significant haemodynamic disturbance in the peri-procedural period. We present three such patients, highlighting some of the potential problems encountered and discuss their possible pathophysiological mechanisms and safety measures.Entities:
Keywords: Chronic heart failure; Left ventricular systolic dysfunction; MitraClip; Mitral regurgitation; Mitral valve; Percutaneous
Year: 2015 PMID: 26635930 PMCID: PMC4660477 DOI: 10.4330/wjc.v7.i11.817
Source DB: PubMed Journal: World J Cardiol